Aarti S. Shah's most recent trade in NVIDIA Corp was a trade of 1,799 Common done . Disclosure was reported to the exchange on June 26, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
NVIDIA | Aarti S. Shah | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2025 | 1,799 | 55,007 (0%) | 0% | 0 | Common | |
NVIDIA | Aarti S. Shah | Director | Sale of securities on an exchange or to another person at price $ 118.36 per share. | 20 Mar 2025 | 9,224 | 61,684 (0%) | 0% | 118.4 | 1,091,792 | Common |
NVIDIA | Aarti S. Shah | Director | Sale of securities on an exchange or to another person at price $ 118.87 per share. | 20 Mar 2025 | 8,476 | 53,208 (0%) | 0% | 118.9 | 1,007,502 | Common |
NVIDIA | Aarti S. Shah | Director | Sale of securities on an exchange or to another person at price $ 116.99 per share. | 20 Mar 2025 | 2,300 | 70,908 (0%) | 0% | 117.0 | 269,083 | Common |
NVIDIA | Aarti S. Shah | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2024 | 2,088 | 73,208 (0%) | 0% | 0 | Common | |
NVIDIA | Aarti S. Shah | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2022 | 1,438 | 6,462 (0%) | 0% | 0 | Common | |
NVIDIA | Aarti S. Shah | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2021 | 429 | 1,256 (0%) | 0% | 0 | Common | |
Eli Lilly | Aarti S. Shah | SVP & CIDO | Grant, award, or other acquisition of securities at price $ 205.77 per share. | 08 Feb 2021 | 11,033 | 31,622 (0%) | 0% | 205.8 | 2,270,260 | Common Stock |
Eli Lilly | Aarti S. Shah | SVP & CIDO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2021 | 4,550 | 4,550 | - | - | Restricted Stock Unit | |
Eli Lilly | Aarti S. Shah | SVP & CIDO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2021 | 6,282 | 23,369 (0%) | 0% | 0 | Common Stock | |
Eli Lilly | Aarti S. Shah | SVP & CIDO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2021 | 6,282 | 0 | - | - | Restricted Stock Unit | |
Eli Lilly | Aarti S. Shah | SVP & CIDO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 207.97 per share. | 01 Feb 2021 | 2,780 | 20,589 (0%) | 0% | 208.0 | 578,157 | Common Stock |
NVIDIA | Aarti S. Shah | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2020 | 426 | 827 (0%) | 0% | 0 | Common | |
NVIDIA | Aarti S. Shah | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2020 | 401 | 401 (0%) | 0% | 0 | Common |